Sign in to view content

Phase 3 Randomized, Double-Masked Studies of Brolucizumab Versus Aflibercept in nAMD: Expanded Primary and Secondary Outcomes From HAWK/HARRIER

Arshad M. Khanani, MD, MA, FASRS

Video
Published 2018

Related

Clinical Feasibility of Ultra-rapid, Non-pharmacologic Anesthesia for Intravitreal Injection in Patients Receiving Anti-VEGF Treatment
Cagri G Besirli, MD, PhD, FASRS
Annual Meeting Talks
2018
Suprachoroidal Triamcinolone Acetonide with and without Intravitreal Aflibercept for Diabetic Macular Edema: Results of the 6-Month Prospective, Phase 1/2 Hulk Study
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2017
Suprachoroidally Injected CLS-TA Improves Visual Acuity and Macular Edema in Noninfectious Uveitis: Results of the Phase 3 PEACHTREE Study
Steven Yeh, MD
Annual Meeting Talks
2018

Category: Age-Related Macular Degeneration

See more